You are here
- Home
- Drug Products
- All Drug Products
An Open-Label, Single Centre Study to Assess the Pharmacokinetics and Pharmacodynamics of Warfarin when Co-Administered with Fostamatinib in Healthy Subjects
- Disease
- rheumatoid arthritis
- Drug Name
- Fostamatinib Disodium
- Generic Name
- FOSTAMATIN
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Mar 16, 2011
- Study Name
- D4300C00013
- Study Id
- D4300C00013
- ClinicalTrials.gov ID
- NCT01311622
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
